Alterity Therapeutics (ATHE) Intangibles (2010 - 2011)
Alterity Therapeutics (ATHE) recorded quarterly Intangibles of $7.4 million in Q2 2011, up 59.18% quarter-over-quarter from $4.6 million in Q2 2010, and up 59.18% on a YoY basis from $4.6 million in Q2 2010.
Alterity Therapeutics (ATHE) Intangibles (2010 - 2011) Analysis & Trends
Alterity Therapeutics' Intangibles history runs 2 years deep, the most recent figure standing at $7.4 million for Q2 2011.
- In Q2 2011, Intangibles rose 59.18% year-over-year to $7.4 million; the TTM figure through Jun 2011 stood at $7.4 million (up 59.18% YoY), while the FY2011 annual figure was $7.4 million, up 59.18% from the prior year.
- Intangibles was $7.4 million for Q2 2011 at Alterity Therapeutics, up from $4.6 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $7.4 million in Q2 2011 to a low of $4.6 million in Q2 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 7.36 Mn |
| Jun 30, 2010 | 4.62 Mn |